LAVAL, Quebec--(BUSINESS WIRE)--Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is...
EXTON, Pa. & SAN DIEGO--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop...
NEW YORK--(BUSINESS WIRE)--BMS & The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
Source Read More
CHICAGO--(BUSINESS WIRE)--PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption of its digital medicine platform....
January 25, 2021 07:00 AM Eastern Standard Time
HEMEL HEMPSTEAD, England & BEIJING, China & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ:...
NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio
Source Read More
